Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Ansys Reports Extension Of Collab With BMW ‘to create the first-ever end-to-end tool chain specifically guided by safety principles to develop and validate ADAS and automated/autonomous driving functions,’ No Terms Disclosed
The BMW Group and Ansys join forces to implement unique simulation capabilities leading to more reliability in automated/autonomous vehicle technology
/ Key Highlights
The BMW Group extends its collaboration with
NASA Reports Awarded ANSYS Of Canonsburg, Pennsylvania For Modeling, Simulation Capabilities, Maximum Potential Contract Value $39.1M
https://www.prnewswire.com/news-releases/nasa-awards-contract-for-modeling-simulation-capabilities-to-ansys-301520470.html
Where Ansys Stands With Analysts
Within the last quarter, Ansys (NASDAQ:ANSS) has observed the following analyst ratings:
What 5 Analyst Ratings Have To Say About Ansys
Over the past 3 months, 5 analysts have published their opinion on Ansys (NASDAQ:ANSS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Credit Suisse Maintains Outperform on Ansys, Lowers Price Target to $389
Credit Suisse analyst John Walsh maintains Ansys (NASDAQ:ANSS) with a Outperform and lowers the price target from $437 to $389.
RBC Capital Maintains Sector Perform on Ansys, Lowers Price Target to $350
RBC Capital analyst Matthew Hedberg maintains Ansys (NASDAQ:ANSS) with a Sector Perform and lowers the price target from $425 to $350.
Ansys Q4 Adj. EPS $2.81 Beats $2.71 Estimate, Sales $661.36M Beat $642.39M Estimate
Ansys (NASDAQ:ANSS) reported quarterly earnings of $2.81 per share which beat the analyst consensus estimate of $2.71 by 3.69 percent. This is a 5.07 percent decrease over earnings of $2.96 per share from the same period
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell
• Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.